H.pylori peptic ulcer disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
Yamuna Kondapally (talk | contribs)
Yamuna Kondapally (talk | contribs)
Line 19: Line 19:
'''Gastric metaplasia'''
'''Gastric metaplasia'''
*H.pylori causes hypergastrinemia and increased sensitivity to gastrin.
*H.pylori causes hypergastrinemia and increased sensitivity to gastrin.
*Gastric metaplasia (the presence of gastric-type mucus secreting cells in the surface epithelium of the duodenum)  occurs as a part of host defence mechanism to protect against the repeated injury caused by arrival of unneutralized acid in the first part of duodenum.<ref name="pmid8730266">{{cite journal| author=Walker MM, Dixon MF| title=Gastric metaplasia: its role in duodenal ulceration. | journal=Aliment Pharmacol Ther | year= 1996 | volume= 10 Suppl 1 | issue=  | pages= 119-28 | pmid=8730266 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8730266  }} </ref><ref name="pmid2617162">{{cite journal| author=Kreuning J, vd Wal AM, Kuiper G, Lindeman J| title=Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease. | journal=Scand J Gastroenterol Suppl | year= 1989 | volume= 167 | issue=  | pages= 16-20 | pmid=2617162 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2617162  }} </ref>
*Gastric metaplasia (the presence of gastric-type mucus secreting cells in the surface epithelium of the duodenum)  occurs as a part of host defence mechanism to protect against the repeated injury caused by arrival of unneutralized acid in the first part of duodenum.<ref name="pmid8730266">{{cite journal| author=Walker MM, Dixon MF| title=Gastric metaplasia: its role in duodenal ulceration. | journal=Aliment Pharmacol Ther | year= 1996 | volume= 10 Suppl 1 | issue=  | pages= 119-28 | pmid=8730266 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8730266  }} </ref><ref name="pmid2617162">{{cite journal| author=Kreuning J, vd Wal AM, Kuiper G, Lindeman J| title=Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease. | journal=Scand J Gastroenterol Suppl | year= 1989 | volume= 167 | issue=  | pages= 16-20 | pmid=2617162 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2617162 }} </ref><ref name="pmid8730266">{{cite journal| author=Walker MM, Dixon MF| title=Gastric metaplasia: its role in duodenal ulceration. | journal=Aliment Pharmacol Ther | year= 1996 | volume= 10 Suppl 1 | issue=  | pages= 119-28 | pmid=8730266 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8730266 }} </ref>
*In response to inflammatory process following arrival of unneutralized acid into duodenum, in the goblet cells transforms to gastric phenotype cells.<ref name="pmid2617162">{{cite journal| author=Kreuning J, vd Wal AM, Kuiper G, Lindeman J| title=Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease. | journal=Scand J Gastroenterol Suppl | year= 1989 | volume= 167 | issue=  | pages= 16-20 | pmid=2617162 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2617162  }} </ref>
*In response to inflammatory process following arrival of unneutralized acid into duodenum, in the goblet cells transforms to gastric phenotype cells.<ref name="pmid2617162">{{cite journal| author=Kreuning J, vd Wal AM, Kuiper G, Lindeman J| title=Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease. | journal=Scand J Gastroenterol Suppl | year= 1989 | volume= 167 | issue=  | pages= 16-20 | pmid=2617162 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2617162  }} </ref>


'''Active chronic duodenitis'''
'''Active chronic duodenitis'''
*The gastric metaplasia provides appropriate site for H.pylori to colonize, giving rise to chronic inflammation.
*


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 17:51, 12 January 2017

Helicobacter pylori infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Gastritis
Peptic ulcer disease
Gastric adenocarcinoma
MALT lymphoma

Causes

Differentiating Helicobacter pylori infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Guideline Recommendation

ACG guidelines
ESPGHAN and NASPGHAN guidelines

History and Symptoms

Physical Examination

Diagnostic tests

Endoscopic tests
Nonendoscopic tests

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

H.pylori peptic ulcer disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of H.pylori peptic ulcer disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on H.pylori peptic ulcer disease pathophysiology

CDC on H.pylori peptic ulcer disease pathophysiology

H.pylori peptic ulcer disease pathophysiology in the news

Blogs on H.pylori peptic ulcer disease pathophysiology

Directions to Hospitals Treating Helicobacter pylori infection

Risk calculators and risk factors for H.pylori peptic ulcer disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Pathophysiology

  • H.pylori is closely associated with both duodenal and gastric ulcers.[1]
  • The estimated lifetime risk for the development of peptic ulcer disease is 10-20%, in patients with H.pylori infection.
  • H.pylori can be diagnosed in 60-100% of gastric ulcer patients and 90-100% in duodenal ulcer patients.

Duodenal Ulceration

  • The patients with higher gastric acid secretion have increased risk of developing duodenal ulcers compared to normal, healthy individuals.
  • The most important requirements for the development of duodenal ulceration are:
  • Gastric metaplasia in the proximal duodenum
  • Active chronic duodenitis

Pathogenesis

Gastric metaplasia

  • H.pylori causes hypergastrinemia and increased sensitivity to gastrin.
  • Gastric metaplasia (the presence of gastric-type mucus secreting cells in the surface epithelium of the duodenum) occurs as a part of host defence mechanism to protect against the repeated injury caused by arrival of unneutralized acid in the first part of duodenum.[2][3][2]
  • In response to inflammatory process following arrival of unneutralized acid into duodenum, in the goblet cells transforms to gastric phenotype cells.[3]

Active chronic duodenitis

  • The gastric metaplasia provides appropriate site for H.pylori to colonize, giving rise to chronic inflammation.

References

  1. Kuipers EJ, Thijs JC, Festen HP (1995). "The prevalence of Helicobacter pylori in peptic ulcer disease". Aliment Pharmacol Ther. 9 Suppl 2: 59–69. PMID 8547530.
  2. 2.0 2.1 Walker MM, Dixon MF (1996). "Gastric metaplasia: its role in duodenal ulceration". Aliment Pharmacol Ther. 10 Suppl 1: 119–28. PMID 8730266.
  3. 3.0 3.1 Kreuning J, vd Wal AM, Kuiper G, Lindeman J (1989). "Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease". Scand J Gastroenterol Suppl. 167: 16–20. PMID 2617162.